Journey Medical (DERM) News Today $6.15 -0.10 (-1.60%) Closing price 05/19/2026 04:00 PM EasternExtended Trading$6.15 0.00 (0.00%) As of 05/19/2026 04:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DERM Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period Journey Medical Corporation to Participate in A.G.P.'s Annual Virtual Healthcare ConferenceMay 19 at 4:45 PM | globenewswire.comQ3 EPS Forecast for Journey Medical Decreased by AnalystMay 18 at 1:24 AM | americanbankingnews.comJourney Medical Rides Emrosi Surge in Earnings CallMay 14, 2026 | tipranks.comJourney Medical Corp (DERM) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ...May 14, 2026 | finance.yahoo.comTranscript: Journey Medical Q1 2026 Earnings Conference CallMay 14, 2026 | finance.yahoo.comJourney Medical Corporation (DERM) reports Q1 loss, beats revenue estimatesMay 14, 2026 | msn.comHere's what key metrics tell us about Journey Medical (DERM) Q1 earningsMay 13, 2026 | msn.comJourney Medical signals positive EBITDA for remainder of 2026 as it plans to add up to 5 sales professionalsMay 13, 2026 | msn.comJourney Medical (DERM) Q1 2026 Earnings TranscriptMay 13, 2026 | finance.yahoo.comJourney Medical Corporation (DERM) Q1 2026 Earnings Call TranscriptMay 13, 2026 | seekingalpha.comJourney Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate HighlightsMay 13, 2026 | globenewswire.comJourney Medical (DERM) Projected to Post Earnings on WednesdayMay 11, 2026 | americanbankingnews.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERMMay 7, 2026 | prnewswire.comJourney Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026May 6, 2026 | globenewswire.comWill Journey Medical Corporation (DERM) report negative Q1 earnings? What you should knowMay 6, 2026 | msn.comJourney Medical (DERM) Expected to Announce Earnings on WednesdayMay 6, 2026 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERMApril 30, 2026 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERMApril 28, 2026 | globenewswire.comQ1 EPS Estimates for Journey Medical Cut by HC WainwrightApril 27, 2026 | marketbeat.comJourney Medical Corporation (NASDAQ:DERM) Receives Average Rating of "Hold" from AnalystsApril 26, 2026 | marketbeat.comQ4 EPS Estimates for Journey Medical Raised by HC WainwrightApril 24, 2026 | marketbeat.comJourney Medical Corporation Secures Contract with Third Major GPO for Emrosi™April 21, 2026 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERMApril 16, 2026 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERMApril 14, 2026 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERMApril 9, 2026 | prnewswire.comJourney Medical Corporation Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their LossesApril 2, 2026 | globenewswire.comWhy The Journey Medical (DERM) Narrative Is Shifting With New Targets And Going Concern RisksMarch 29, 2026 | finance.yahoo.comJourney Medical Corporation (NASDAQ:DERM) Q4 2025 Earnings Call TranscriptMarch 27, 2026 | insidermonkey.comJourney Medical Rides Emrosi Surge Toward ProfitabilityMarch 26, 2026 | tipranks.comJourney Medical Corp (DERM) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...March 26, 2026 | uk.finance.yahoo.comJourney Medical targets expanded Emrosi coverage and EBITDA growth through 2026 amid robust prescription demandMarch 25, 2026 | seekingalpha.comJourney Medical Corporation (DERM) Q4 2025 Earnings Call TranscriptMarch 25, 2026 | seekingalpha.comJourney Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate HighlightsMarch 25, 2026 | globenewswire.comJourney Medical Corp (DERM) Q4 2025: Everything You Need To Know Ahead Of EarningsMarch 24, 2026 | finance.yahoo.comJourney Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026March 18, 2026 | globenewswire.comJourney Medical: Emrosi Is Winning, But The Stock Hasn't NoticedJanuary 23, 2026 | seekingalpha.com9 Best Performing Micro Cap Stocks in 2025January 9, 2026 | insidermonkey.comJourney Medical (DERM) Publishes Positive Emrosi Phase 1 Microbiome DataJanuary 9, 2026 | msn.comPublic companies account for 34% of Journey Medical Corporation's (NASDAQ:DERM) ownership, while institutions account for 33%December 22, 2025 | finance.yahoo.comJourney Medical announces results from phase 1 trial of DFD-29December 10, 2025 | msn.comJourney Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of ...December 10, 2025 | finance.yahoo.comJourney Medical Corporation Reports Positive Phase 1 Trial Results for Emrosi, Meeting All Primary Objectives with No Safety IssuesDecember 10, 2025 | quiverquant.comQJourney Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in DermatologyDecember 10, 2025 | globenewswire.comWhat Makes Journey Medical Corporation (DERM) a Good Investment?November 19, 2025 | finance.yahoo.comJourney Medical Corp (DERM) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ...November 18, 2025 | finance.yahoo.comJourney Medical (DERM) Price Target Increased by 12.50% to 13.77November 17, 2025 | msn.comJourney Medical’s Earnings Call Highlights Growth and ChallengesNovember 13, 2025 | tipranks.comJourney Medical Corporation (DERM) Q3 2025 Earnings Call TranscriptNovember 12, 2025 | seekingalpha.comJourney Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate HighlightsNovember 12, 2025 | globenewswire.comWhat To Expect From Journey Medical Corp (DERM) Q3 2025 EarningsNovember 12, 2025 | finance.yahoo.com Get Journey Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for DERM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DERM Media Mentions By Week DERM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DERM News Sentiment▼-0.510.38▲Average Medical News Sentiment DERM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DERM Articles This Week▼203▲DERM Articles Average Week Get the Latest News and Ratings for DERM and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Journey Medical and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Fortress Biotech News Today Valneva News Today Immix Biopharma News Today Aquestive Therapeutics News Today Shattuck Labs News Today Ginkgo Bioworks News Today ProKidney News Today Aura Biosciences News Today REGENXBIO News Today Tectonic Therapeutic News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DERM) was last updated on 5/20/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredI’m sounding the alarmMeta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...Porter & Company | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredHe doesn't buy gold. He just profits from it.Former hedge fund manager Larry Benedict generated $274 million in profits - and Barron's ranked his fund in t...Brownstone Research | SponsoredThe Iran War Just Broke the Gold MarketThe Iran war isn't just a geopolitical event. It's a financial one. Within hours of the strikes, oil surged...Behind the Markets | SponsoredHow to Access Elon’s “Monster” Interest RateMost Americans earn just 0.4% on their savings - that's $40 a year on $10,000. A new banking alternative is of...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Journey Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Journey Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
